Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

The Biggest News of 2022: TCTMD’s Top 10

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

December 30, 2022

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

What’s Going to Be Hot at ESC 2022?

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

August 22, 2022

TCTMD’s Top 10 Most Popular Stories for July 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

August 01, 2022

Heart Failure Risks of Smoking Can Linger for Decades

News Daily News

Heart Failure Risks of Smoking Can Linger for Decades

June 07, 2022

TCTMD’s Top 10 Most Popular Stories for May 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

June 01, 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

May 25, 2022

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

May 05, 2022

Infertility in Women Linked to Subsequent Risk of HFpEF

News Daily News

Infertility in Women Linked to Subsequent Risk of HFpEF

April 19, 2022

New HF Guidelines Stress Four Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 01, 2022

TCTMD’s Top 10 Most Popular Stories for March 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2022

April 01, 2022

April 2022 News Roundup

News Opinion CV Team Dispatch

April 2022 News Roundup

April 01, 2022

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

March 22, 2022

TCTMD’s Top 10 Most Popular Stories for February 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2022

February 28, 2022

FDA Approves Empagliflozin for Treatment of HFpEF

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

February 07, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.